Use of Technetium-99m-labeled Lipophilic Complex of Methoxyisobutyl-isonitrile and lopromide Radiopaque Substance to Assess the Severity of Coronary Atherosclerosis in Patients with Coronary Heart Disease at Mild Disorders of Myocardial Perfusion

摘要

In this study we used technetium-99m-labeled lipophilic complex of methoxy-isobutylisonitrile (~(99m)Tc-MIBI) and iopromide to assess coronary atherosclerosis in patients with coronary artery disease (CAD). The study included 33 patients with CAD who underwent myocardial perfusion scintigraphy with ~(99m)Tc-MIBI and computed tomography angiography (MDCTA) with iopromide. Patients who have comparable with the population-wide level risk of coronary events are characterized by the presence of borderline and significant stenosis 83% and 86%, respectively. ~(99m)Tc-MIBI and iopromide can be used to assess the severity of coronary atherosclerosis in patients with CAD.